Walk down the beverage aisle, and you’ll notice something odd: The organizing principle isn’t flavor anymore. It’s health function-based. “Gut.” “Calm.” “Focus.” “Immunity.”
The labels read less like refreshment and more like a gentler version of the health-supplement shelf. Consumers increasingly shop for functional beverages the way they shop for over-the-counter drugs: by the benefit they’re seeking.
This purchase behavior is no longer fringe. Mordor Intelligence estimates that North American functional beverage sales were around $58 billion in 2025 and projects them to reach around $82.85 billion by 2031. SPINS notes that for 2026, “function forward” beverages show some of the strongest growth in subcategories such as energy, protein, mood support, and no-sugar.
Consumers as savvy CEOs
A quantified-self mindset has trained consumers to expect data-backed ingredients, transparent dosing, and credible substantiation. Capital followed attention. “Consumers are becoming the CEOs of their own health,” as Deloitte explains.
Since 2021, publicly disclosed growth rounds for a small set of functional (and functional-adjacent) brands have already exceeded $300 million, including Olipop ($30 million in 2022, then $50 million in 2025), Poppi ($25 million in 2022) and Recess ($30 million in 2025).
“Better-for-you” neighbors include Athletic Brewing ($50 million in 2024, according to Bevnet) and Liquid Death ($67 million in 2024, according to Bevnet). So the totals only represent the floor, not a full market total.
And incumbents aren’t only buying, they’re upgrading legacy flagships into indulgences with benefits. Pepsi launched Pepsi Prebiotic Cola. Coca-Cola launched Simply Pop, its own prebiotic soda under a trusted masterbrand.
For challengers, offering a benefit won’t be enough. In crowded need states, new entrants need distinctive formulation, defensible claims, packaging, and positioning that lead consumers to choose them even when a familiar giant offers a cheaper, “good-enough” alternative.
Trust is the choke point. As claims rise, scrutiny rises as well. Poppi’s gut-healthy claims drew a class-action suit and ended in an $8.9 million settlement. A separate class action was filed against Olipop in late 2025, challenging digestive-benefit advertising. In a pharmacy-like aisle, credibility becomes the scarce resource.
The road to Beverage 3.0
If Beverage 1.0 was convenience and Beverage 2.0 was lifestyle, Beverage 3.0 is repeatable health benefits.
Brands that outperform build a repeatable foundation of belief by creating science-backed products with proven efficacy, strong potency, and stability, while reinforcing trust through community engagement and credible validation.
They pair the above with disciplined execution. This includes excellent distribution, modern go-to-market capabilities across social, search, and retail marketing, and targeted, strategically deployed total video campaigns.
Beverage 3.0 has given rise to new international players like the Swedish-founded GOOD IDEA sparkling water and the Swiss-engineered KA-EX (a company we’ve invested in) that address issues such as glycemic control and cortisol management, respectively.
Successful Beverage 3.0 companies are science-backed, built around clear need states, and powered by strong communities that earn consumer trust through the most effective mix of social and trusted mass media.
In the future, we can look forward to Beverage 4.0, which will bring more tailored-made formulations that address multiple consumer needs and will be tied to measurement platforms and feedback loops.
Diana Florescu is the CEO and founding partner of MFG (mediaforgrowth).